November 2019 is Prostate Cancer Awareness Month

Prostate Cancer Awareness Month brings attention to the men living with this disease. Pharma Intelligence’s Report Store is offering 20% off select prostate cancer reports covering key marketed and pipeline drugs, clinical trials, and more.

Use code: prostate20 at checkout to instantly get 20% discount.

Related Reports

This report includes a discussion of leading products, new technologies, market forecasts, drivers and limiters, competitors, trends & opportunities in the nearly $1bn Prostate Cancer Diagnostics and Minimally Invasive Treatments market.

Prostate cancer is a hormonally fueled disease, and the most common form of cancer found in males. Consequently, there is a high incentive for drug development in this indication due to its large population size.


The prostate cancer market has become saturated in the metastatic castration-resistant prostate cancer (CRPC) setting; the approval of second-generation antiandrogens, radiotherapies, and chemotherapies has resulted in a great deal of development targeting earlier stages of the disease.